- Home
- POWL vs SBFM Comparison
POWL vs SBFM Comparison
Compare POWL & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWL
- SBFM
- Stock Information
- Founded
- POWL 1947
- SBFM 2006
- Country
- POWL United States
- SBFM United States
- Employees
- POWL N/A
- SBFM 52
- Industry
- POWL Electrical Products
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- POWL Energy
- SBFM Health Care
- Exchange
- POWL Nasdaq
- SBFM Nasdaq
- Market Cap
- POWL N/A
- SBFM 4.9M
- IPO Year
- POWL N/A
- SBFM N/A
- Fundamental
- Price
- POWL $167.24
- SBFM $1.25
- Analyst Decision
- POWL Strong Buy
- SBFM Strong Buy
- Analyst Count
- POWL 1
- SBFM 1
- Target Price
- POWL $312.00
- SBFM $15.00
- AVG Volume (30 Days)
- POWL 377.0K
- SBFM 3.7M
- Earning Date
- POWL 04-29-2025
- SBFM 05-19-2025
- Dividend Yield
- POWL 0.64%
- SBFM N/A
- EPS Growth
- POWL 106.54
- SBFM N/A
- EPS
- POWL 13.17
- SBFM N/A
- Revenue
- POWL $1,059,770,000.00
- SBFM $34,874,283.00
- Revenue This Year
- POWL $13.99
- SBFM $192.48
- Revenue Next Year
- POWL $3.99
- SBFM N/A
- P/E Ratio
- POWL $12.70
- SBFM N/A
- Revenue Growth
- POWL 38.27
- SBFM 44.75
- 52 Week Low
- POWL $123.04
- SBFM $1.19
- 52 Week High
- POWL $364.98
- SBFM $91.40
- Technical
- Relative Strength Index (RSI)
- POWL 43.65
- SBFM 27.96
- Support Level
- POWL $162.28
- SBFM $1.36
- Resistance Level
- POWL $181.25
- SBFM $1.65
- Average True Range (ATR)
- POWL 13.02
- SBFM 0.31
- MACD
- POWL 0.06
- SBFM -0.04
- Stochastic Oscillator
- POWL 43.71
- SBFM 2.97
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.